Clinical Trial Update: Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing aspirin dose effects on atherosclerosis in patients with metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Metabolic Syndrome

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Florida Atlantic University | Conditions: Cardiovascular Diseases, Metabolic Syndrome X | Phase 4 | Status: COMPLETED | Results posted: 2012-06-19